# Patient Characteristics and Treatment Modalities in COPD Patients in China

> **NCT03161587** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 848 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03161587
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-31
- **Primary completion:** 2018-12-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 848 (ACTUAL)
- **Last updated:** 2019-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03161587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03161587, "Patient Characteristics and Treatment Modalities in COPD Patients in China". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03161587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*